MROPF (MicroPort CardioFlow Medtech) Total Stockholders Equity: $256.23 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MROPF MicroPort CardioFlow Medtech Corp MROPF
60 GF Score
Price $0.65
GF Value $3.18
! 11 Warning Signs
View Full Analysis

What is MicroPort CardioFlow Medtech Total Stockholders Equity?

MicroPort CardioFlow Medtech MROPF 60 Total Stockholders Equity is $256.23 Mil as of Dec. 2025. GuruFocus rates MROPF with a GF Score™ of 60/100 and a GF Value™ of $3.18. The stock has 11 warning signs investors should review.

MicroPort CardioFlow Medtech's Total Stockholders Equity for the quarter that ended in Dec. 2025 was $256.23 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. MicroPort CardioFlow Medtech's Book Value per Share for the quarter that ended in Dec. 2025 was $0.20. The ratio of a company's debt over equity can be used to measure how leveraged this company is. MicroPort CardioFlow Medtech's Debt-to-Equity for the quarter that ended in Dec. 2025 was 0.91.

MicroPort CardioFlow Medtech  (OTCPK:MROPF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

MicroPort CardioFlow Medtech's Book Value per Share for the quarter that ended in Dec. 2025 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(256.232-0)/1273.028
=0.20

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

MicroPort CardioFlow Medtech's Debt-to-Equity for the quarter that ended in Dec. 2025 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(23.444 + 208.791) / 256.232
=0.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech Total Stockholders Equity Related Terms

MicroPort CardioFlow Medtech Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for MicroPort CardioFlow Medtech's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech Total Stockholders Equity Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial 485.79 399.13 329.66 304.27 256.23

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 329.66 297.27 304.27 304.27 256.23
MROPF
60GF Score
MicroPort CardioFlow Medtech Corp MROPF
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of $256.23 Mil mean?
MicroPort CardioFlow Medtech (MROPF) has a Total Stockholders Equity of $256.23 Mil as of Dec. 2025. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for MicroPort CardioFlow Medtech and its competitors.
Is MicroPort CardioFlow Medtech's Total Stockholders Equity too high?
MicroPort CardioFlow Medtech's current Total Stockholders Equity is $256.23 Mil. Overall, MicroPort CardioFlow Medtech has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does MicroPort CardioFlow Medtech's Total Stockholders Equity compare to ABT and SYK?
MicroPort CardioFlow Medtech's Total Stockholders Equity of $256.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Medical Devices & Instruments company?
A good Total Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for MicroPort CardioFlow Medtech and its competitors. MicroPort CardioFlow Medtech's current Total Stockholders Equity is $256.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MicroPort CardioFlow Medtech stock overvalued right now?
MicroPort CardioFlow Medtech (MROPF) has a current Total Stockholders Equity of $256.23 Mil. The stock's GF Value™ is $3.18, compared to a current price of $0.65 — trading 79.7% below its estimated fair value. The current Total Stockholders Equity is $256.23 Mil. MicroPort CardioFlow Medtech's overall GF Score™ is 60/100 with 11 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For MicroPort CardioFlow Medtech (MROPF), the current Total Stockholders Equity is $256.23 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MicroPort CardioFlow Medtech (MROPF) Overvalued in 2026?

Based on GuruFocus' analysis, MicroPort CardioFlow Medtech stock appears to be undervalued. The current stock price of $0.65 is trading 79.7% below its estimated GF Value™ of $3.18.

Key valuation signals for MROPF:

  • Total Stockholders Equity: $256.23 Mil
  • GF Value™: $3.18 vs. price of $0.65 (79.7% below fair value)
  • GF Score™: 60/100 with 11 warning signs

No single metric tells the full story. See the MROPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

MicroPort CardioFlow Medtech Business Description

Other Exchanges 02160:Hong Kong72X0:Germany
Address No. 501 Niudun Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of VitaFlow, VitaFlow Liberty, Angelguide and AnchorMan. The Group derives revenue from the sales of medical devices through appointed distributors. It derives maximum revenue from PRC.
60GF Score

Get the complete analysis for MROPF

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price
$3.18
GF Value